The World Health Organization (WHO) has issued an emergency approval for the Novavax drug against COVID-19, which has thus become the 10th vaccine available in the fight against the rapidly spreading disease.
The US-developed NOVAVAX vaccine against COVID-19 has been approved Monday by the European Medicines Agency (EMA), thus becoming the fifth drug of its kind to become available at a continental level.
India has bought 1.6 billion doses of Covid-19 vaccines, which is more than any other country, according to a global analysis. Using its massive manufacturing clout, the country purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the American company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, said the USA-based Duke University Global Health Innovation Centre.